TPCW
DXCM icon

TD Private Client Wealth’s DexCom DXCM Stock Holding History

TD Private Client Wealth’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Buy
1,732
+324
+23% +$21.6K ﹤0.01% 751
2026
Q1 		$88.4K Buy
1,408
+696
+98% +$48.5K ﹤0.01% 776
2025
Q4 		$47.3K Sell
712
-11,575
-94% -$748K ﹤0.01% 885
2025
Q3 		$827K Buy
12,287
+11,965
+3,716% +$947K 0.02% 399
2025
Q2 		$28.1K Sell
322
-171
-35% -$13.4K ﹤0.01% 939
2025
Q1 		$33.7K Buy
493
+60
+14% +$4.9K ﹤0.01% 864
2024
Q4 		$33.7K Buy
433
+167
+63% +$12.4K ﹤0.01% 888
2024
Q3 		$17.8K Sell
266
-274
-51% -$22.5K ﹤0.01% 980
2024
Q2 		$61.2K Sell
540
-33
-6% -$4.17K ﹤0.01% 775
2024
Q1 		$79.5K Buy
573
+16
+3% +$2.01K ﹤0.01% 729
2023
Q4 		$69.1K Sell
557
-14
-2% -$1.43K ﹤0.01% 761
2023
Q3 		$53.3K Sell
571
-91
-14% -$10.3K ﹤0.01% 761
2023
Q2 		$85.1K Buy
662
+61
+10% +$7.38K ﹤0.01% 688
2023
Q1 		$69.8K Sell
601
-12
-2% -$1.34K ﹤0.01% 704
2022
Q4 		$69.4K Buy
613
+175
+40% +$19.2K ﹤0.01% 677
2022
Q3 		$35.3K Buy
438
+77
+21% +$6.52K ﹤0.01% 799
2022
Q2 		$26.9K Sell
361
-27
-7% -$2.46K ﹤0.01% 857
2022
Q1 		$49.6K Sell
388
-148
-28% -$16.2K ﹤0.01% 773
2021
Q4 		$72K Buy
536
+112
+26% +$16.1K ﹤0.01% 689
2021
Q3 		$58K Buy
424
+104
+33% +$13.1K ﹤0.01% 725
2021
Q2 		$34.2K Buy
320
+180
+129% +$17.3K ﹤0.01% 789
2021
Q1 		$12.6K Buy
140
+56
+67% +$5.26K ﹤0.01% 870
2020
Q4 		$7.76K Sell
84
-208
-71% -$18.6K ﹤0.01% 859
2020
Q3 		$30.1K Sell
292
-52
-15% -$5.43K ﹤0.01% 686
2020
Q2 		$34.9K Buy
344
+124
+56% +$11.1K ﹤0.01% 655
2020
Q1 		$14.8K Sell
220
-32
-13% -$1.99K ﹤0.01% 723
2019
Q4 		$13.8K Buy
+252
New +$12K ﹤0.01% 732

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

TD Private Client Wealth's DXCM Position: Q2 2026 in Review

TD Private Client Wealth increased its DexCom (DXCM) stake by 23% in Q2 2026, buying an estimated $21.6K and bringing the position to 1,732 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #751.

TD Private Client Wealth first reported a position in DXCM in Q4 2019 and has held it in 27 quarters since. The position peaked at $827K in Q3 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • TD Private Client Wealth held 1,732 shares of DexCom worth $117K as of Q2 2026.
  • TD Private Client Wealth bought 324 DexCom shares in Q2 2026, an estimated $21.6K.
  • DexCom made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #751 holding.
  • TD Private Client Wealth first reported a position in DexCom in Q4 2019 and has held it in 27 quarters since.
  • TD Private Client Wealth's DexCom position peaked at $827K in Q3 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.